文献速递细菌感染、耐药与抗菌药物

Lynronne-1与EDTA对牛乳腺炎病原体的协同抗菌活性

Synergistic antimicrobial activity of lynronne-1 and EDTA against bovine mastitis pathogens.
PubMed 文献 · J Antimicrob Chemother · 2025-01-01

本研究评估了5种抗菌肽和2种生物活性化合物对35株牛乳腺炎病原体的抗菌效果。Lyn-1与EDTA表现出最广谱的抗菌活性,联合应用FICI值为0.1至0.5提示协同作用,12小时内可使活菌数降低超过10000倍,且在8倍MIC浓度下无溶血性,但高于MIC浓度时观察到细胞毒性。

要点

  • Lyn-1与EDTA联合对35株牛乳腺炎病原体显示协同抗菌作用,FICI值为0.1至0.5。
  • 联合方案在12小时内使活菌数降低超过10000倍。
  • 联合方案在8倍MIC浓度内无溶血性,但高于MIC浓度时观察到细胞毒性。

核心结论

  • Lyn-1及Lyn-1-EDTA联合方案具有开发无抗生素制剂以对抗传染性和环境性乳腺炎病原体及治疗乳房感染的潜力。

研究设计与样本

  • 评估5种抗菌肽(Lynronne-1、Lynronne-2、Bovicin HC5、AMP 660、AMP 1043)和2种生物活性化合物(EDTA二钠、单月桂酸甘油酯)对35株牛乳腺炎病原体的抗菌效果。
  • 计算部分抑菌浓度指数(FICI)以判定相互作用,FICI≤0.5提示协同作用。
  • 进行时间依赖性杀菌试验评估联合方案的杀菌效力。
  • 采用MTT法评估细胞毒性,并针对新鲜牛红细胞评估溶血活性。

主要发现

  • Lyn-1和EDTA表现出最高的广谱抗菌活性,分别使细菌生长(OD600 nm)降低95.1%和86.9%。
  • FICI值为0.1至0.5,提示协同作用。
  • Lyn-1(0.03 mg/mL)与EDTA(1.02 mg/mL)联合对所有菌株的抗菌活性高于各化合物单用,且浓度显著更低。
  • Lyn-1-EDTA联合在12小时内使活菌数降低超过10000倍。
  • 联合方案在高达8倍MIC浓度下无溶血性(P > 0.05),但高于MIC浓度时观察到细胞毒性(P < 0.01)。

关键数值与推荐

  • FICI≤0.5提示协同作用,本研究FICI值为0.1至0.5。
  • Lyn-1(0.03 mg/mL)与EDTA(1.02 mg/mL)联合对所有菌株的抗菌活性高于各化合物单用,且浓度显著更低。
  • 联合方案在12小时内使活菌数降低超过10000倍。
  • 联合方案在高达8倍MIC浓度下无溶血性(P > 0.05)。
  • 联合方案在高于MIC浓度时观察到细胞毒性(P < 0.01)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bovine mastitis is the costliest disease in the dairy sector and the main cause of antibiotic use in dairy cattle, potentially contributing to the antimicrobial resistance crisis. Antimicrobial peptides (AMPs) offer promise as antibiotic alternatives for controlling mastitis pathogens. METHODS: The efficacy of five AMPs (Lynronne-1 [Lyn-1], Lynronne-2 [Lyn-2], Bovicin HC5, AMP 660, and AMP 1043) and two bioactive compounds (disodium ethylenediaminetetraacetic acid [EDTA] and glycerol monolaurate) was assessed against a range of 35 mastitis-causing pathogens. The fractional inhibitory concentrations index (FICI) was calculated to determine the interaction effect and values ≤0.5 were indicative of synergism. Time-dependent killing assays were performed to assess bactericidal efficacy of the combination. Cytotoxicity was evaluated using the MTT assay and haemolytic activity was assessed against fresh bovine erythrocytes. RESULTS: Lyn-1 and EDTA exhibited the highest broad spectrum antimicrobial activity and reduced bacterial growth (OD600 nm) by 95.1% and 86.9%, respectively. FICI values ranged from 0.1 to 0.5, indicating synergism. The combination of lyn-1 (0.03 mg/mL) and EDTA (1.02 mg/mL) exhibited higher antimicrobial activity against all bacterial strains, at significantly lower concentrations than each compound individually. Lyn-1-EDTA combination reduced viable population by >10 000-fold within 12 h. The combination was non-haemolytic in concentrations up to 8-fold the established MIC values (P > 0.05), although cytotoxic effects were observed at concentrations above MIC (P < 0.01). CONCLUSIONS: These findings highlight the therapeutic potential of Lyn-1 and Lyn-1-EDTA for developing antibiotic-free formulations to combat contagious and environmental mastitis pathogens and treat udder infections.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Moreira AJS, de Araújo Domingues KC, Camargo KDV, et al. Synergistic antimicrobial activity of lynronne-1 and EDTA against bovine mastitis pathogens. J Antimicrob Chemother. 2025. PMID: 39582247. doi:10.1093/jac/dkae425

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。